tHEORetically Speaking
Menu Close
  • Home
  • Guest Authors
  • About Us
  • HealthEconomics.Com
  • HE Jobs Portal

amit dang

0

Achieving Market Access in India – Are You Hitting the Mark? An Interview with Marksman Healthcare Solutions CEO Dr. Amit Dang

Posted on July 10, 2014 by Patti Peeples, R.Ph., Ph.D.

It’s well-accepted that the Indian pharmaceuticals market cannot be ignored.  India will be one of the top 10 sales markets by 2020, fueled by the rapid growth in its population and economy.  Commensurately, India is experiencing expansion within its middle-class… Continue Reading →

India market access, Real-World Evidence amit dang, clinical trials, Evidence-based medicine, global, health economics, health economics & outcomes research, Health technology assessment, HealthEconomics.Com, HEOR, india, Market Access, marketing, marksman healthcare solutions, outcomes research, patient reported outcomes, patti peeples, payers, real world evidence

About the HealthEconomics.Com Blog:

Insights, observations, executive interviews, critical analysis, and new research for health economics, outcomes research, real-world evidence, and market access community. We welcome guest bloggers.

Check your inbox or spam folder to confirm your subscription.

Recent Posts

  • How Accelerated Drug Development Requires Disruption in Market Access and Pricing
  • The UK market access has always been complex, now even more than before, Graham Foxon and Paul Craddy?
  • How to Change Clinical Practice Using Health Economics and Outcomes Research
  • Switzerland is strong in many aspects, so also in its health care system, Dr. Peter Indra?

HealthEconomics.Com Twitter Feed

HealthEconomics.Com | A Scientist.com Company Follow

www_healthecon
www_healthecon HealthEconomics.Com | A Scientist.com Company @www_healthecon ·
2h

Essential Terms for UK Quality Regulations Post-Brexit

http://ow.ly/QmFb50KihON

#HEOR #Pharma #UK #HTA #Biotech

Reply on Twitter 1557848706380341248 Retweet on Twitter 1557848706380341248 Like on Twitter 1557848706380341248 Twitter 1557848706380341248
www_healthecon HealthEconomics.Com | A Scientist.com Company @www_healthecon ·
3h

Pharma Preps Legal Strategy Against New US Drug Pricing Regulation

http://ow.ly/ITj550Kieg8

#HEOR #Pharma #DrugPrices #Biotech

Reply on Twitter 1557825628900134912 Retweet on Twitter 1557825628900134912 Like on Twitter 1557825628900134912 1 Twitter 1557825628900134912
www_healthecon HealthEconomics.Com | A Scientist.com Company @www_healthecon ·
6h

What’s driving the need for early stage asset price & value prediction? What are the top reasons for #Pricing & #MarketAccess challenges? Preeti Patel from @PricingGlobal answers these questions & more in this tHEORetically speaking interview! Read here: http://bit.ly/3QbPLWW

Reply on Twitter 1557790139396530179 Retweet on Twitter 1557790139396530179 Like on Twitter 1557790139396530179 Twitter 1557790139396530179
Load More...

Archives

Visit our website, HealthEconomics.Com, top ranked by Google for news, jobs and resources in healthcare value, market access and more. Read our privacy policy here.
© 2022 tHEORetically Speaking. All rights reserved.
Hiero by aThemes